250 related articles for article (PubMed ID: 15791438)
41. Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients.
Lasnon C; Desmonts C; Quak E; Gervais R; Do P; Dubos-Arvis C; Aide N
Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):985-96. PubMed ID: 23564036
[TBL] [Abstract][Full Text] [Related]
42. An alternative parameter for early forecasting clinical response in NSCLC patients during radiotherapy: proof of concept study.
Padovani L; Baret A; Ciccolini J; Taieb D; Bardia F; Teissonnier L; Muracciole X; Barlesi F; Barbolosi D
Br J Radiol; 2016 Jun; 89(1062):20160061. PubMed ID: 27043244
[TBL] [Abstract][Full Text] [Related]
43. Time course of tumor SUV in 18F-FDG PET of breast cancer: presentation of a simple model using a single reference point for time corrections of tumor SUVs.
Stahl AR; Heusner TA; Hartung V; Nagarajah J; Bockisch A; Hahn S; Antoch G; Jentzen W
J Nucl Med; 2011 Jan; 52(1):18-23. PubMed ID: 21149481
[TBL] [Abstract][Full Text] [Related]
44. Noise reduction in oncology FDG PET images by iterative reconstruction: a quantitative assessment.
Riddell C; Carson RE; Carrasquillo JA; Libutti SK; Danforth DN; Whatley M; Bacharach SL
J Nucl Med; 2001 Sep; 42(9):1316-23. PubMed ID: 11535719
[TBL] [Abstract][Full Text] [Related]
45. Evaluating FDG uptake changes between pre and post therapy respiratory gated PET scans.
Aristophanous M; Yong Y; Yap JT; Killoran JH; Allen AM; Berbeco RI; Chen AB
Radiother Oncol; 2012 Mar; 102(3):377-82. PubMed ID: 22265731
[TBL] [Abstract][Full Text] [Related]
46. Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography.
Miles KA; Griffiths MR; Keith CJ
Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):22-8. PubMed ID: 16180030
[TBL] [Abstract][Full Text] [Related]
47. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.
Higashi K; Ueda Y; Arisaka Y; Sakuma T; Nambu Y; Oguchi M; Seki H; Taki S; Tonami H; Yamamoto I
J Nucl Med; 2002 Jan; 43(1):39-45. PubMed ID: 11801701
[TBL] [Abstract][Full Text] [Related]
48. Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods.
Krak NC; van der Hoeven JJ; Hoekstra OS; Twisk JW; van der Wall E; Lammertsma AA
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):674-81. PubMed ID: 12640556
[TBL] [Abstract][Full Text] [Related]
49. Verification of the tumor volume delineation method using a fixed threshold of peak standardized uptake value.
Koyama K; Mitsumoto T; Shiraishi T; Tsuda K; Nishiyama A; Inoue K; Yoshikawa K; Hatano K; Kubota K; Fukushi M
Radiol Phys Technol; 2017 Sep; 10(3):311-320. PubMed ID: 28676945
[TBL] [Abstract][Full Text] [Related]
50. Postinjection transmission scanning in myocardial 18F-FDG PET studies using both filtered backprojection and iterative reconstruction.
van der Weerdt AP; Boellaard R; Knaapen P; Visser CA; Lammertsma AA; Visser FC
J Nucl Med; 2004 Feb; 45(2):169-75. PubMed ID: 14960632
[TBL] [Abstract][Full Text] [Related]
51. Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF.
Doot RK; Dunnwald LK; Schubert EK; Muzi M; Peterson LM; Kinahan PE; Kurland BF; Mankoff DA
J Nucl Med; 2007 Jun; 48(6):920-5. PubMed ID: 17504870
[TBL] [Abstract][Full Text] [Related]
52. 18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer.
Eschmann SM; Friedel G; Paulsen F; Reimold M; Hehr T; Budach W; Langen HJ; Bares R
Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):463-71. PubMed ID: 17103167
[TBL] [Abstract][Full Text] [Related]
53. Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues.
Paquet N; Albert A; Foidart J; Hustinx R
J Nucl Med; 2004 May; 45(5):784-8. PubMed ID: 15136627
[TBL] [Abstract][Full Text] [Related]
54. Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer.
Lasnon C; Hicks RJ; Beauregard JM; Milner A; Paciencia M; Guizard AV; Bardet S; Gervais R; Lemoel G; Zalcman G; Aide N
Clin Nucl Med; 2012 Oct; 37(10):971-6. PubMed ID: 22899197
[TBL] [Abstract][Full Text] [Related]
55. Comparison of methodologies for the in vivo assessment of 18FLT utilisation in colorectal cancer.
Visvikis D; Francis D; Mulligan R; Costa DC; Croasdale I; Luthra SK; Taylor I; Ell PJ
Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):169-78. PubMed ID: 15129698
[TBL] [Abstract][Full Text] [Related]
56. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
Kitagawa Y; Sano K; Nishizawa S; Nakamura M; Ogasawara T; Sadato N; Yonekura Y
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):63-71. PubMed ID: 12483411
[TBL] [Abstract][Full Text] [Related]
57. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
[TBL] [Abstract][Full Text] [Related]
58. Influence of Statistical Fluctuation on Reproducibility and Accuracy of SUVmax and SUVpeak: A Phantom Study.
Akamatsu G; Ikari Y; Nishida H; Nishio T; Ohnishi A; Maebatake A; Sasaki M; Senda M
J Nucl Med Technol; 2015 Sep; 43(3):222-6. PubMed ID: 26271802
[TBL] [Abstract][Full Text] [Related]
59. Quantitative comparison of analytic and iterative reconstruction methods in 2- and 3-dimensional dynamic cardiac 18F-FDG PET.
Lubberink M; Boellaard R; van der Weerdt AP; Visser FC; Lammertsma AA
J Nucl Med; 2004 Dec; 45(12):2008-15. PubMed ID: 15585474
[TBL] [Abstract][Full Text] [Related]
60. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
